Back to search

Inactivation of the p53 protein in cell lines derived from human esophageal cancers

Data up to Jan 2025

Published1997
Citations71
References34

Total Citations Per Year

Abstract

References (34)

Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations

1994 • 2,460 citations

p53: puzzle and paradigm.

1996 • 2,363 citations

Estimates of the worldwide incidence of eighteen major cancers in 1985

1993 • 1,680 citations

p53: A Frequent Target for Genetic Abnormalities in Lung Cancer

1989 • 1,214 citations

Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma

1993 • 884 citations

A transcriptionally active DNA-binding site for human p53 protein complexes.

1992 • 729 citations

Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.

1994 • 580 citations

Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation

1996 • 508 citations

Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor.

1992 • 417 citations

Frequent mutation of the p53 gene in human esophageal cancer.

1990 • 393 citations

p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.

1991 • 349 citations

Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: A review

1996 • 299 citations

Loss of p53 function through PAX-mediated transcriptional repression.

1995 • 236 citations

PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms’ tumors

1992 • 223 citations

Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines.

1992 • 213 citations

Molecular basis for heterogeneity of the human p53 protein.

1986 • 167 citations

Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis.

1991 • 165 citations

p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.

1991 • 150 citations

Retinoblastoma and p 53 tumor suppressor genes in human hepatoma cell lines

1993 • 128 citations

Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.

1993 • 118 citations

Characterization of the human p53 gene promoter.

1989 • 108 citations

The tumor suppressor protein p53

1995 • 98 citations

Specific DNA binding by different classes of human p53 mutants.

1995 • 81 citations

PAX5 expression correlates with increasing malignancy in human astrocytomas.

1995 • 79 citations

The tumor suppressor protein p53

1995 • 74 citations

Characterization ofp53 gene mutations in esophageal squamous cell carcinoma cell lines: Increased frequency and different spectrum of mutations from primary tumors

1996 • 51 citations

Loss of heterozygosity of the short arm of chromosomes 3 and 9 in oral cancer

1996 • 49 citations

Expression and stability of p53 protein in normal human mammary epithelial cells

1993 • 46 citations

Epidemiology of oesophageal cancer

1994 • 30 citations

p53 mutations in esophageal tumors from high‐incidence areas of China

1995 • 30 citations

mRNA and protein expression of p53 mutations in human bladder cancer cell lines

1994 • 27 citations

Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines.

1996 • 22 citations

Genomic DNA and messenger rna expression alterations of the CDKN2B and CDKN2 genes in esophageal squamous carcinoma cell lines

1995 • 16 citations

A unique p53 intragenic deletion flanked by short direct repeats results in loss ofmRNA expression in a human esophageal carcinoma

1994 • 8 citations

Cited By (0)

No citing papers found in database

Inactivation of the p53 protein in cell lines derived from human esophageal cancers (1997) – International Journal of Cancer | Metascience Observatory Explorer